Ideas for healing

News & Media

Press, webinars, research and articles from our team.

20 press features and talks 9 studies behind our care

In the press

Coverage, interviews and talks

Evidence behind the care

What the studies show, and what researchers are still learning. Every paper is linked in full.

  1. 01

    FDA-approved

    Spravato® for difficult-to-treat depression

    Clinical trials support esketamine for adults whose depression has not improved with previous treatments; since January 2025 it is also FDA-approved as a standalone treatment.

    American Journal of Psychiatry 2019

    Read the study (opens in a new tab)
  2. 02

    Meta-analysis

    Ketamine for treatment-resistant depression

    In real-world data, ketamine produced rapid, meaningful relief where other treatments had not.

    Journal of Psychiatric Research 2022

    Read the review (opens in a new tab)
  3. 03

    Clinical study

    Ketamine for treatment-resistant PTSD

    In a real-world setting, IV ketamine brought rapid, lasting relief from PTSD symptoms unresponsive to other care.

    Journal of Psychopharmacology 2024

    Read the study (opens in a new tab)
  4. 04

    Systematic review

    Ketamine paired with psychotherapy

    A review of the evidence for combining ketamine with therapy to deepen and extend results.

    Journal of Pain Research 2022

    Read the review (opens in a new tab)

Visit & start

Meet us in Santa Monica. Clinic tours are free, with no obligation.